trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['bcsm', 'daiichisankyous', 'astrazenecaus', 'astrazeneca']
 if tdxd isn t approved for her2 low won t insurance companies balk at paying for it? and it ain t cheap. will and seek fda approval in her 2 low? #asco22 #bcsm #financialtoxicity
(former) doctor, mother, woman LIVING with metastatic breast cancer. Grant reviewer. Conference goer. METAvivor board member. She/her. #NotDeadYet for 8 years